News & Events about Minerva Surgical Inc.
Thinking about buying stock in Minerva Surgical, Lucid, Rivian, IBM, or NVIDIA? Thinking about buying stock in Minerva Surgical, Lucid, Rivian, IBM, or NVIDIA? PR Newswire NEW YORK, Jan. 26, 2023 NEW YORK, Jan. 26, 2023 /PRNewswire/ --InvestorsObserverissues critical PriceWatch Alerts for UTRS...
Thinking about buying stock in Minerva Surgical, IQIYI, Cosmos Health, Acasti Pharma, or AMC Entertainment? Thinking about buying stock in Minerva Surgical, IQIYI, Cosmos Health, Acasti Pharma, or AMC Entertainment? PR Newswire NEW YORK, Dec. 28, 2022 NEW YORK, Dec. 28, 2022 /PRNewswire...
Minerva Surgical (NASDAQ:UTRS Get Rating) was downgraded by Zacks Investment Research from a hold rating to a sell rating in a research note issued to investors on Wednesday, Zacks.com reports. According to Zacks, Minerva Surgical is a commercial-stage medical technology company focused on ...
Ticker Report
8 months ago
Minerva Surgical (NASDAQ:UTRS Get Rating) had its price objective reduced by Piper Sandler from $12.00 to $6.00 in a research note issued to investors on Thursday morning, The Fly reports. Separately, Zacks Investment Research downgraded shares of Minerva Surgical from a buy rating to a hold...